Carbon Dots with Absorption Red-Shifting for Two-Photon Fluorescence Imaging of Tumor Tissue pH and Synergistic Phototherapy

Carbon Dots with Absorption Red-Shifting for Two-Photon Fluorescence Imaging of Tumor Tissue pH and Synergistic Phototherapy
复制标题

具有吸收红移的碳点用于肿瘤组织 pH 值的双光子荧光成像和协同光疗

DOI:
10.1021/acsami.1c08076
复制
发表时间:
2021-07-21
影响因子:
9.5
通讯作者:
Zhao, Shulin
Zhao, Shulin
中科院分区:
材料科学2区
文献类型:
--
作者:
Bai, Yulong;Zhao, Jingjin;Zhao, Shulin

文献摘要

被引文献

相似文献

光疗法作为一种新型的肿瘤治疗方法具有巨大的潜力,高活性光敏剂和光热剂的开发引起了人们的广泛关注。以赖氨酸、邻苯二胺和硫酸为原料,采用水热法制备了具有吸收红移效应的硫氮共掺杂碳量子点(S,N-CD)。S、N-CD的近红外(NIR)吸收特性导致双光子(TP)发射,其已分别用于溶酶体和肿瘤组织pH的TP荧光成像以及肿瘤光疗过程中细胞凋亡的实时监测。所获得的杂原子共掺杂的CD不仅可以用作NIR成像探针,而且可以用作有效的光动力疗法/光热疗法(PDT/PTT)治疗剂。比较了不同杂原子掺杂的CD在肿瘤治疗中的效率。结果表明,S,N-CD比N掺杂CD具有更高的治疗效率,O-1(2)的产生效率为27%,光热转换效率达到34.4%。该研究为碳基纳米药物的合成提供了新的见解,用于协同光疗和肿瘤的准确诊断。
Phototherapy exhibits significant potential as a novel tumor treatment method, and the development of highly active photosensitizers and photothermal agents has drawn considerable attention. In this work, S and N atom co-doped carbon dots (S,N-CDs) with an absorption redshift effect were prepared by hydrothermal synthesis with lysine, o-phenylenediamine, and sulfuric acid as raw materials. The near-infrared (NIR) absorption features of the S,N-CDs resulted in two-photon (TP) emission, which has been used in TP fluorescence imaging of lysosomes and tumor tissue pH and real-time monitoring of apoptosis during tumor phototherapy, respectively. The obtained heteroatom co-doped CDs can be used not only as an NIR imaging probe but also as an effective photodynamic therapy/photothermal therapy (PDT/PTT) therapeutic agent. The efficiencies of different heteroatom-doped CDs in tumor treatment were compared. It was found that the S,N-CDs showed higher therapeutic efficiency than N-doped CDs, the efficiency of producing O-1(2) was 27%, and the photothermal conversion efficiency reached 34.4%. The study provides new insight into the synthesis of carbon-based nanodrugs for synergistic phototherapy and accurate diagnosis of tumors.